Europe Oligonucleotide Synthesis Market to 2027 - Regional Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)
Publication Month: Oct 2019
Report Code: TIPRE00007128 No. of Pages: 163 Category: Biotechnology Status: Published
The Europe Oligonucleotide Synthesis market is expected to reach US$ $ 1,270.95 Mn in 2027 from US$ 518.02 Mn in 2018. The market is estimated to grow with a CAGR of 13.7% from 2019-2027.
The growth of the market is driven by the factors such as, research and academic universities are collaborating with commercial market players to develop techniques and simplify the method of artificial DNA synthesis as well as rise in the number of market players and their focus in the oligonucleotide synthesis are likely to boost the growth of the oligonucleotide synthesis in the region during the forecast period.
Synthetic DNA is widely used in biology. Oligonucleotides are used in many biological and forensic applications as sequence-specific binding agents can help in identifying presence of a specific target DNA sequence. Synthetic oligonucleotides are short stretches of single stranded DNA fragments assembled by chemical synthesis. Due to the simultaneous developments of methods for the rapid and efficient synthesis of oligonucleotides and the advent of molecular biology techniques.
Oligonucleotides have many applications in research, diseases diagnosis, therapeutics, forensic, drug discovery, agriculture and many more. Synthetic oligonucleotides are widely used in the diagnosis of human genetic diseases. In addition, the players operating in the UK oligonucleotide synthesis market have been obtaining funds in order to enhance their product offering. For instance, in March, 2019, UK based privately held biotech company, Procarta Biosystems received a fund of US$ 1.69 Mn (€1.5 m) from the Novo Holdings REPAIR Impact Fund in order to enable the development of novel therapies to combat antimicrobial resistance (AMR).
Researchers are also using oligonucleotides to produce more efficient, greener chemical synthesis. By assembling oligonucleotides together into longer fragments that encode synthetic genes, bacteria or yeast cells can be instructed to produce specific enzymes (a type of protein).
Oligonucleotides also has wide potential for treating various medical conditions. They enable the development of therapeutics as the malfunctioning genes can be targeted, manipulated, silenced and/or modulated. For instance, Ionis Pharmaceuticals has dedicated its existence to oligonucleotide therapeutic development, particularly antisense oligonucleotide (ASO) therapeutics. Thus, the promising potential of synthesized oligonucleotides in various fields drives the market growth.
Spain is expected to lead the market in the Europe region owing to growing number of partnerships and collaborations among private players, rising investments and funding dedicated to the biotechnology companies as well as academic and research institutes for gene synthesis based end products. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
Exhibit: Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
EUROPE OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION
By Product
- Synthesized Oligonucleotides
- Primers
- Probes
- Large-Scale Synthesis
- Others
- Reagents
- Equipment
By Application
- Research
- Diagnostics
- Therapeutics
By End User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Companies
- Diagnostic Laboratories
- Other End Users
By Geography
- Europe
- US
- Canada
- Mexico
Company Profiles
- Thermo Fisher Scientific Inc.
- GenScript
- Molecular Assemblies
- Twist Biosciences
- Evonetix
- DNA Script
- Nuclera Nucleics
- Camena Bioscience
- Synthomics
- Ansa Biotechnologies
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. Europe Oligonucleotide Synthesis Market – Key Takeaways
3. Europe Oligonucleotide Synthesis Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Europe Oligonucleotide Synthesis Market – By Product
3.2.2 Europe Oligonucleotide Synthesis Market – By Application
3.2.3 Europe Oligonucleotide Synthesis Market – By End User
3.2.4 Europe Oligonucleotide Synthesis Market – By Country
3.3 PEST Analysis
3.3.1 Europe – PEST Analysis
4. Europe Oligonucleotide Synthesis Market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Heavy Investments by European Private Players in Synthetic Biology
4.1.2 Synthesized Oligonucleotides to Treat Medical Conditions
4.1.3 Rising Number of Research and Development Activities in Synthetic Biology
4.2 Key Market Restraints
4.2.1 Frequently Changing EU Regulatory Policies for Biotechnology Industry
4.2.2 Biotechnology Sector Lacks Skilled Professionals
4.3 Key Market Opportunities
4.3.1 Collaborations — The Future of Innovation
4.4 Future Trends
4.4.1 New Product Developments in Synthetic Biology
4.5 Impact Analysis
5. Oligonucleotide Synthesis – Europe Analysis
5.1 Europe Oligonucleotide Synthesis Market Revenue Forecasts And Analysis
5.2 Market Positioning
5.3 Performance Of Key Players
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 GenScript
5.4 Expert Opinions
6. Europe Oligonucleotide Synthesis Market Analysis –By Product
6.1 Overview
6.2 Europe Oligonucleotide Synthesis Market, By Product, 2018 & 2027 (%)
6.3 Synthesized Oligonucleotides Market
6.3.1 Overview
6.3.2 Europe Synthesized Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.3 Primers Market
6.3.3.1 Overview
6.3.3.2 Europe Primers Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4 Probes Market
6.3.4.1 Overview
6.3.4.1.1 Europe Probes Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.2 Large-Scale Synthesis Oligonucleotides Market
6.3.4.2.1 Overview
6.3.4.2.2 Europe Large-Scale Synthesis Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.3.4.3 Others Market
6.3.4.3.1 Overview
6.3.4.3.2 Europe Others Oligonucleotides Market Revenue and Forecasts to 2027 (US$ Mn)
6.4 Reagents Market
6.4.1 Overview
6.4.2 Europe Reagents Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Equipment Market
6.5.1 Overview
6.5.2 Europe Equipment Market Revenue and Forecasts to 2027 (US$ Mn)
7. Europe Oligonucleotide Synthesis Market Analysis – By Application
7.1 Overview
7.2 Europe Oligonucleotide Synthesis Market, By Application, 2018 & 2027 (%)
7.3 Research Market
7.3.1 Overview
7.3.2 Europe Research Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Diagnostics Market
7.4.1 Overview
7.4.2 Europe Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Therapeutics Market
7.5.1 Overview
7.5.2 Europe Therapeutics Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Oligonucleotide Synthesis Market Analysis –By End User
8.1 Overview
8.2 Europe Oligonucleotide Synthesis Market, By End User, 2018 & 2027 (%)
8.3 Academic Research Institutes Market
8.3.1 Overview
8.3.2 Europe Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Diagnostic Laboratories Market
8.4.1 Overview
8.4.2 Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Pharmaceutical & Biotechnology Companies Market
8.5.1 Overview
8.5.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Other End Users Market
8.6.1 Overview
8.6.2 Europe Other End Users Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027
9.1 Overview
9.1.1 Europe Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.2.1 Europe Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.3 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.4 Europe Oligonucleotide Synthesis market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.5 Europe Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Country (%)
9.1.6 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 UK Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.6.2.1 UK Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.6.3 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.6.4 UK Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.7 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Germany Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.7.2.1 Germany Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.7.3 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.7.4 Germany Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 France Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 France Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.8.2.1 France Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.8.3 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.8.4 France Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 Italy Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Italy Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.9.2.1 Italy Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.9.3 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.9.4 Italy Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.10 Spain Oligonucleotide Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.1 Spain Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.10.2 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Product (US$ Mn)
9.1.10.2.1 Spain Synthesized Oligonucleotides Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9.1.10.3 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By Application (US$ Mn)
9.1.10.4 Spain Oligonucleotide Synthesis Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Oligonucleotide Synthesis Market –Industry Landscape
10.1 Overview
10.2 Comparative Company Analysis
10.3 Growth Strategies Done By The Companies In The Market, (%)
10.4 Organic Developments
10.4.1 Overview
10.5 Inorganic Developments
10.5.1 Overview
11. Oligonucleotide Synthesis Market–Key Company Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 GenScript
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Synthomics, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Ansa Biotechnologies, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Iridia, Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Helixworks
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Keasling Lab
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Molecular Assemblies
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Twist Bioscience
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Evonetix
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Dna Script
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Financial overview
11.11.4 Product Portfolio
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Nuclera Nucleics Ltd.
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Financial Overview
11.12.4 Product Portfolio
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Camena Bio
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Financial Overview
11.13.4 Product Portfolio
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 2. Europe Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 3. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 4. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 5. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 6. UK Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 7. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 8. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 9. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 10. Germany Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 11. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 12. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 13. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 14. France Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 15. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 16. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 17. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 18. Italy Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 19. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 20. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 21. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Product (US$ Mn)
Table 22. Spain Synthesized Oligonucleotides Market Revenue And Forecasts To 2027, By Type (US$ Mn)
Table 23. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Application (US$ Mn)
Table 24. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic Developments Done By Companies
Table 27. Glossary Of Terms, Oligonucleotide Synthesis Market
LIST OF FIGURES
Figure 1. France Oligonucleotide Synthesis Market, Revenue (Us$ Bn), By 2018 & 2027
Figure 2. Europe Synthesized Oligonucleotides Market By Product, Market Share (%), 2018
Figure 3. Europe Oligonucleotide Synthesis Market By Application, Market Share (%), 2018
Figure 4. Europe Oligonucleotide Synthesis Market By End User, Market Share (%), 2018
Figure 5. Oligonucleotide Synthesis Market Segmentation
Figure 6. Europe PEST Analysis
Figure 7. Oligonucleotide Synthesis Market Impact Analysis Of Driver And Restraints
Figure 8. Europe Oligonucleotide Synthesis Market – Revenue Forecasts And Analysis – 2017- 2027
Figure 9. Europe Oligonucleotide Synthesis Market By Product, 2018 & 2027 (%)
Figure 10. Europe Synthesized Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 11. Europe Primers Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 12. Europe Probes Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 13. Europe Large-Scale Synthesis Oligonucleotides Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 14. Europe Others Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 15. Europe Reagents Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 16. Europe Equipment Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 17. Europe Oligonucleotide Synthesis Market By Application, 2018 & 2027 (%)
Figure 18. Europe Research Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 19. Europe Diagnostics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 20. Europe Therapeutics Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 21. Europe Oligonucleotide Synthesis Market By End User, 2018 & 2027 (%)
Figure 22. Europe Academic Research Institutes Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 23. Europe Diagnostic Laboratories Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 24. Europe Pharmaceutical & Biotechnology Companies Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 25. Europe Other End Users Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 26. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 27. Europe Oligonucleotide Synthesis Market Revenue And Forecasts To 2027, By Country (%)
Figure 28. UK Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 29. Germany Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 30. France Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 31. Italy Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 32. Spain Oligonucleotide Synthesis Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 33. Comparative Company Analysis
Figure 34. Growth Strategies Done By The Companies In The Market, (%)
The List of Companies
- Thermo Fisher Scientific Inc.
- GenScript
- Molecular Assemblies
- Twist Biosciences
- Evonetix
- DNA Script
- Nuclera Nucleics
- Camena Bioscience
- Synthomics
- Ansa Biotechnologies
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe oligonucleotide synthesis market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe oligonucleotide synthesis market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution